Answer
The outer structure of some prolonged-release tablets may remain visible after the active ingredient has been released. Available evidence has not shown reduced treatment response from this finding.
Sources for this answer
- Nevirapine 400 mg prolonged-release tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.